期刊文献+

甲基苯丙胺所致精神障碍的相关因素分析 被引量:2

The analysis of correlated factors of methamphetamine-induced psychosis
原文传递
导出
摘要 目的:探讨影响甲基苯丙胺所致精神障碍的病程和症状严重程度的可能因素。方法:采用回顾性研究方法,中了解人口学信息、甲基苯丙胺使用情况及简明精神病评定量表(BPRS)评分,共61例患者纳入分析,使用多元线性回归(进入法)进行统计分析。结果:精神障碍病程与甲基苯丙胺使用时间正相关(B=2. 422,P=0. 002),BPRS总分与开始使用毒品的年龄负相关(B=-0. 493,P=0. 028)。结论:甲基苯丙胺滥用时间、开始使用甲基苯丙胺的年龄可以作为甲基苯丙胺所致精神障碍严重程度的预测因素。 Objective: The objective of this study was to determine the correlated factor of methamphetamine-induced psychosis ( MIP) in patients with methamphetamine ( MA) dependence.Methods: By adopting the method of retrospective study,general demographic and clinical data were collected from medical records when patients were admitted to Shenzhen Kangning Hospital. Brief Psychiatric Rating Scale( BPRS) scores were collected from medical records . 61patients were included to the analysis. All the data were analyzed by multivariable linear regression( enter).Results: The duration of MIP was positively correlated with periods of MA exposure ( B = 2. 422,P = 0. 002). BPRS total score was negatively correlated with age of onset of MA use ( B =- 0. 493,P = 0. 028).Conclusion: The longer period exposure of MA predicts the longer that psychosis is likely to last. The earlier one start to abuse MA the more severe MIP symptoms they produced.
作者 杨传青 孔志 刘奋 王周然 杨梅 YANG Chuanqing;KONG Zhi;LIU Fen;WANG Zhouran;YANG Mei(Medical Records and Statistics Department of Shenzhen Kangning Hospital, Shenzhen Mental Health Laboratory,Shenzhen,518020;Drug Dependent Department of Shenzhen Kangning Hospital, Shenzhen Mental Health Laboratory,Shenzhen,518020)
出处 《中国药物依赖性杂志》 CAS CSCD 2019年第2期135-138,共4页 Chinese Journal of Drug Dependence
基金 深圳市科技计划项目(JCYJ20160429185634596)资助
关键词 甲基苯丙胺 甲基苯丙胺所致精神障碍 相关因素 methamphetamine methamphetamine-induced psychosis correlated factor
  • 相关文献

参考文献3

二级参考文献39

  • 1张玉竹,王振国.北京地区高学历吸毒者的情况分析[J].中国药物依赖性杂志,2005,14(6):437-439. 被引量:13
  • 2United Nations Office on Drug and Crime (UNODC).World Drug Report 2010.http://www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html.
  • 3中国国家禁毒委员会.2010中国禁毒报告.北京,2011.
  • 4Wallace LS,Keenum AJ,DeVoe JE.Characteristics of container labeling in a sample of commonly prescribed children's oral medications.Res Social Adm Pharm,6(4):272-279.
  • 5Leamon MH,Flower K,Salo RE,Nordahl TE,Kranzler HR,Galloway GP.Methamphetamine and paranoia:the methamphetamine experience questionnaire.Am J Addict,2010,19(2):155-168.
  • 6Shoptaw S,Peck J,Reback CJ,Rotheram-Fuller E.Psychiatric and substance dependence comorbidities,sexually transmitted diseases,and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.J Psychoactive Drugs,2003,35 Suppl 1:161-168.
  • 7Sato M.A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis.Ann N Y Acad Sci,1992,654:160-170.
  • 8Grant KM,Levan TD,Wells SM,Li M,Stoltenberg SF,Gendelman HE,et al.Methamphetamine-associated psychosis.J Neuroimmune Pharmacol,2011.doi:10.1007/s11481-011-9288-1.
  • 9Ujike H,Sato M.Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.Ann N Y Acad Sci,2004,1025:279-287.
  • 10Brady KT,Gray KM,Tolliver BK.Cognitive enhancers in the treatment of substance use disorders:clinical evidence.Pharmacol Biochem Behav,2011,99(2):285-294.

共引文献47

同被引文献18

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部